Your account is not claimed yet. You can sign up with ORCID to claim your account.

James M Stone (James Stone)

Scopus Author ID Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 26

Top Venues

Journal of psychopharmacology (Oxford, England)

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Early intervention in psychiatry

Schizophrenia bulletin

King's College London

University of London (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

King's College London Sep 1o 2013 - Aug 31o 2020

United Kingdom

Clinical Senior Lecturer :: Institute of Psychiatry

Education History

University of London Sep 1o 2005 - Feb 1o 2008

United Kingdom

PHD

Publications

Sameer Jauhar, Robert A McCutcheon, Mattia Veronese, Faith R Borgan, Matthew Nour, Maria Rogdaki, Fiona Pepper, James M Stone, Alice Egerton, George Vamvakas, Federico Edoardo Turkheimer, Philip K McGuire, Oliver D Howes
The relationship between striatal dopamine and anterior cingulate glutamate in first episode psychosis changes with antipsychotic treatment. Translational psychiatry 13 (1) (2023)
Morgan Hadley, Alicia Halliday, James M Stone
Association of Hallucinogen Persisting Perception Disorder with Trait Neuroticism and Mental Health Symptoms. Journal of psychoactive drugs (2023)
Natalya Marie Leistiko, Louay Madanat, Wing Kwan Antonia Yeung, James M Stone
Effects of gamma frequency binaural beats on attention and anxiety. Current psychology (New Brunswick, N.J.) (2023)
Natalya Marie Leistiko, Louay Madanat, Wing Kwan Antonia Yeung, James M Stone
Effects of gamma frequency binaural beats on attention and anxiety. Current psychology (New Brunswick, N.J.) (2023)
Katherine Beck, Atheeshaan Arumuham, Stefan Brugger, Robert A McCutcheon, Mattia Veronese, Barbara Santangelo, Colm J McGinnity, Joel Dunn, Stephen J Kaar, Nisha Singh, Toby Pillinger, Faith Borgan, Teresa Sementa, Radhouene Neji, Sameer Jauhar, Franklin Aigbirhio, Istvan Boros, Federico Turkheimer, Alexander Hammers, David Lythgoe, James M Stone, Oliver D Howes
The association between <i>N</i>-methyl-d-aspartate receptor availability and glutamate levels: A multi-modal PET-MR brain imaging study in first-episode psychosis and healthy controls. Journal of psychopharmacology (Oxford, England) 36 (9) (2022)
Amanda Kiemes, Maria Elisa Serrano Navacerrada, Eugene Kim, Karen Randall, Camilla Simmons, Loreto Rojo Gonzalez, Marija-Magdalena Petrinovic, David J Lythgoe, Diana Rotaru, Davide Di Censo, Lydiane Hirschler, Emmanuel L Barbier, Anthony C Vernon, James M Stone, Cathy Davies, Diana Cash, Gemma Modinos
Erbb4 Deletion From Inhibitory Interneurons Causes Psychosis-Relevant Neuroimaging Phenotypes. Schizophrenia bulletin (2022)
Oli Sparasci, Kamaldeep S Bhui, Asit Biswas, Samuel Robin Chamberlain, Bernadka Dubicka, Robert B Dudas, Saeed Farooq, Tamsin Jane Ford, Nusrat Husain, Ian R Jones, Helen Killaspy, William Lee, Anne Lingford-Hughes, Ciaran Mulholland, Judy Rubinsztein, Rohit Shankar, Aditya Narain Sharma, Lindsey Isla Sinclair, James M Stone, Allan H Young
Impact of COVID-19 on mental health research: is this the breaking point? The British journal of psychiatry : the journal of mental science (2022)
Amanda Kiemes, Maria Elisa Serrano Navacerrada, Eugene Kim, Karen Randall, Camilla Simmons, Loreto Rojo Gonzalez, Marija-Magdalena Petrinovic, David J Lythgoe, Diana Rotaru, Davide Di Censo, Lydiane Hirschler, Emmanuel L Barbier, Anthony C Vernon, James M Stone, Cathy Davies, Diana Cash, Gemma Modinos
Erbb4 Deletion From Inhibitory Interneurons Causes Psychosis-Relevant Neuroimaging Phenotypes. Schizophrenia bulletin (2022)
Amanda Kiemes, Felipe V Gomes, Diana Cash, Daniela L Uliana, Camilla Simmons, Nisha Singh, Anthony Christopher Vernon, Federico Turkheimer, Cathy Davies, James M Stone, Anthony A Grace, Gemma Modinos
GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (2021)
Katherine Beck, Atheeshaan Arumuham, Mattia Veronese, Barbara Santangelo, Colm J McGinnity, Joel T Dunn, Robert A McCutcheon, Stephen J Kaar, Nisha Singh, Toby Pillinger, Faith R Borgan, James M Stone, Sameer Jauhar, Teresa Sementa, Federico Edoardo Turkheimer, Alexander Hammers, Oliver D Howes
N-methyl-D-aspartate receptor availability in first-episode psychosis: a PET-MR brain imaging study. Translational psychiatry 11 (1) (2021)
Luke A Jelen, James M Stone
Ketamine for depression. International review of psychiatry (Abingdon, England) 33 (3) (2021)
Robert A Chesters, Fiona Pepper, Celia Morgan, Jonathan D Cooper, Oliver D Howes, Anthony C Vernon, James M Stone
Brain volume in chronic ketamine users - relationship to sub-threshold psychotic symptoms and relevance to schizophrenia. Psychopharmacology (2021)
Gemma Modinos, Anja Richter, Alice Egerton, Ilaria Bonoldi, Matilda Azis, Mathilde Antoniades, Matthijs Bossong, Nicolas Crossley, Jesus Perez, James M Stone, Mattia Veronese, Fernando Zelaya, Anthony A Grace, Oliver D Howes, Paul Allen, Philip McGuire
Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomes. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 46 (8) (2021)
Viktoriya L Nikolova, Anthony J Cleare, Allan H Young, James M Stone
Updated Review and Meta-Analysis of Probiotics for the Treatment of Clinical Depression: Adjunctive vs. Stand-Alone Treatment. Journal of clinical medicine 10 (4) (2021)
Aimee Brinn, James M Stone
Neutrophil-lymphocyte ratio across psychiatric diagnoses: a cross-sectional study using electronic health records. BMJ open 10 (7) (2020)
Melissa Hobbs, Rashmi Patel, Paul D Morrison, Nicola J Kalk, James M Stone
Synthetic cannabinoid use in psychiatric patients and relationship to hospitalisation: A retrospective electronic case register study. Journal of psychopharmacology (Oxford, England) 34 (6) (2020)
Thomas A Pollak, Matthew J Kempton, Conrad Iyegbe, Angela Vincent, Sarosh R Irani, Ester Coutinho, David A Menassa, Leslie Jacobson, Lieuwe de Haan, Stephan Ruhrmann, Gabriele Sachs, Anita Riecher-Rössler, Marie-Odile Krebs, Paul Amminger, Birte Glenthøj, Neus Barrantes-Vidal, Jim van Os, Bart P F Rutten, Rodrigo A Bressan, Mark van der Gaag, Robert Yolken, Matthew Hotopf, Lucia Valmaggia, James M Stone, Anthony S David, null null, Philip McGuire
Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis. Molecular psychiatry 26 (6) (2020)
Luke A Jelen, Allan H Young, James M Stone
Ketamine: A tale of two enantiomers. Journal of psychopharmacology (Oxford, England) 35 (2) (2020)
Oliver D Howes, Ilaria Bonoldi, Robert A McCutcheon, Matilda Azis, Mathilde Antoniades, Matthijs Bossong, Gemma Modinos, Jesus Perez, James M Stone, Barbara Santangelo, Mattia Veronese, Anthony Grace, Paul Allen, Philip K McGuire
Glutamatergic and dopaminergic function and the relationship to outcome in people at clinical high risk of psychosis: a multi-modal PET-magnetic resonance brain imaging study. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 45 (4) (2019)
Kate Merritt, Rocio Perez-Iglesias, Kyra-Verena Sendt, Rhianna Goozee, Sameer Jauhar, Fiona Pepper, Gareth J Barker, Birte Glenthøj, Celso Arango, Shôn Lewis, René Kahn, James M Stone, Oliver Howes, Paola Dazzan, Philip McGuire, Alice Egerton
Remission from antipsychotic treatment in first episode psychosis related to longitudinal changes in brain glutamate. NPJ schizophrenia 5 (1) (2019)
Thomas R E Barnes, Richard Drake, Carol Paton, Stephen J Cooper, Bill Deakin, I Nicol Ferrier, Catherine J Gregory, Peter M Haddad, Oliver D Howes, Ian Jones, Eileen M Joyce, Shôn Lewis, Anne Lingford-Hughes, James H MacCabe, David Cunningham Owens, Maxine X Patel, Julia Ma Sinclair, James M Stone, Peter S Talbot, Rachel Upthegrove, Angelika Wieck, Alison R Yung
Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology. Journal of psychopharmacology (Oxford, England) 34 (1) (2019)
Gemma Modinos, Fatma Şimşek, Matilda Azis, Matthijs Bossong, Ilaria Bonoldi, Carly Samson, Beverly Quinn, Jesus Perez, Matthew R Broome, Fernando Zelaya, David J Lythgoe, Oliver D Howes, James M Stone, Anthony A Grace, Paul Allen, Philip McGuire
Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 43 (13) (2018)
James M Stone, Simon Roux, David Taylor, Paul D Morrison
First-generation versus second-generation long-acting injectable antipsychotic drugs and time to relapse. Therapeutic advances in psychopharmacology 8 (12) (2018)
Adisha Kapila, Helen L Fisher, Sonia Johnson, Barnaby Major, Nikola Rahaman, John Joyce, Nick Chamberlain-Kent, Jo Lawrence, Allan H Young, James M Stone
Clinical and demographic differences between patients with manic, depressive and schizophrenia-spectrum psychoses presenting to Early Intervention Services in London. Early intervention in psychiatry 13 (3) (2017)
Aikaterini Rammou, Helen L Fisher, Sonia Johnson, Barnaby Major, Nikola Rahaman, Nick Chamberlain-Kent, James M Stone
Negative symptoms in first-episode psychosis: Clinical correlates and 1-year follow-up outcomes in London Early Intervention Services. Early intervention in psychiatry 13 (3) (2017)
Luke A Jelen, Sinead King, James M Stone
Alternatives to ketamine in depression: state-of-the-art and future perspectives. Therapeutic advances in psychopharmacology 8 (3) (2017)

James M Stone.css-eqlu8i{font-size:small;padding-left:4px;} (James Stone)

Publication Activity (10 Years)

Top Topics

Top Venues

James M Stone (James Stone)